ロード中...
Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults
BACKGROUND. There are no clinical trials specifically addressing chemotherapy for adults with Ewing sarcoma (ES). Five‐year event‐free survival (EFS) of adults on pediatric studies of ES (44%–47%) is worse than that of children treated with the same therapy (69%). The object of this study was to rev...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AlphaMed Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5634776/ https://ncbi.nlm.nih.gov/pubmed/28710342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0464 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|